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INTRODUCTION 
 
Extra-Hepatic Portal Vein Obstruction is one of the vascular 
disorders of the liver. It is said to occur when there is obstruction to the 
extra hepatic part of the portal vein with or without the involvement of the 
intrahepatic part, splenic vein or the superior mesenteric vein. [1]                           
In children, it accounts for nearly 70% of the cases of portal hypertension 
and is the commonest cause of upper GI bleed in them.[2] In Adults, EHPVO 
is responsible for nearly one-third of cases of portal hypertension.[3] 
 Etiologically, EHPVO is a heterogeneous disease and the cause varies 
with respect to age and geographic location. Umbilical sepsis, umbilical 
vein catheterisation, intra-abdominal sepsis, congenital malformations of 
the portal vein, hypercoagulable states, trauma have all been documented 
as possible etiological factors. [4-7] However, despite the best of efforts, a 
clear aetiology remains elusive in a vast majority of cases. 
  Patients with EHPVO can present in two clinical forms: 1) Acute form 
and 2) Chronic form, with the latter being distinctly more common than the 
former. In its acute form, patients may present with acute abdominal pain 
sometimes associated with low grade fever and rarely as transient ascites. 
2 
 
In its more common Chronic form, patients present with variceal bleeding, 
moderate to massive splenomegaly and features suggestive of 
hypersplenism. Rarely patients may present with jaundice secondary to 
portal biliopathy. 
    
Hepatic encephalopathy or porto-systemic encephalopathy refers to 
the spectrum of neuropsychiatric disturbances seen in patients with liver 
disease. It ranges from sub-clinical neurological impairment to frank coma. 
The occurrence of spontaneously occurring overt hepatic encephalopathy 
is distinctly rare in patients with EHPVO.[8] Minimal Hepatic 
encephalopathy at one end of the HE spectrum,  refers to subtle intellectual 
deficits and abnormalities in psychomotor performance that is clinically in-
apparent but evident on performing specialized psychometric tests.[9-11] 
Though the occurrence of minimal hepatic encephalopathy has been well 
documented in patients with cirrhosis, its occurrence in EHPVO, in the 
absence of inherent liver disease is much less explored.  Preliminary 
studies in adults have suggested the possible existence of MHE.[12-14]                    
The prevalence of MHE in children with EHPVO and its impact when 
present, have not been studied.  
 
3 
 
 
This study aims to evaluate children with EHPVO for the existence of 
MHE by using Psychometric tests and Critical flicker Frequency. I believe 
that establishing the presence of MHE in children with EHPVO would lay 
the foundation for treatment modalities, with the potential to improve 
scholastic performance and overall intellectual and psychological 
development of these children. 
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REVIEW OF LITERATURE 
DEFINITION: 
According to the Baveno V consensus, EHPVO is deﬁned as the 
obstruction of the extra-hepatic portion of the portal vein with or without 
involvement of the intra-hepatic portal branches. [15]  
  In other words it indicates portal hypertension due to blockade of the 
portal vein before it enters the liver. The term EHPVO however, does not 
include isolated thrombosis of splenic vein or superior mesenteric vein.  
EHPVO is considered a vascular hepatic disorder. Most of these 
patients do not have any inherent parenchymal liver disease. Consequently, 
portal vein obstruction, which can commonly occur in the setting of 
cirrhosis or hepatocellular carcinoma is generally not considered to be a 
part of EHPVO. [16] 
The term portal vein thrombosis does not exactly reflect the 
condition of EHPVO as the term “Portal Vein Thrombosis” does not exclude 
the isolated thrombosis of intrahepatic part of the portal vein which occurs 
in cirrhosis or the invasion of portal vein by hepatocellular carcinoma. 
Moreover, the term also does not include the development of the portal 
cavernoma that is pathognomonic of the condition in its chronic form. 
Hence the term EHPVO has come into acceptance, to denote the distinct 
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condition in which there is obstruction at the level of the extrahepatic part 
of the portal vein in an otherwise normal liver. 
 
EPIDEMIOLOGY 
EHPVO is one of the commonest causes of Portal Hypertension in the 
developing world, accounting for 30-55% of all variceal bleeds. It is second 
to cirrhosis as the cause of portal hypertension (up to 13%) in the West. [17]      
It is the most common cause of Upper GI bleeding in the paediatric 
population and accounts for nearly 70% of children with PHT.[2]  
 
INDIAN SCENARIO: 
 Studies in Indian children have shown that EHPVO is responsible for 
54% of portal hypertension. [18] Almost 85-92% of the UGI bleed in Indian 
children was secondary to portal hypertension due to EHPVO. [17] 
  Literature from India also suggests that most of these children with 
EHPVO belong to low and lower-middle socio-economic strata. The 
increased incidence of neo-natal umbilical sepsis and recurrent gastro-
intestinal infections, more common in children of lower socio-economic 
groups probably explains this epidemiological phenomenon. Over the years 
it has also been observed that the incidence of EHPVO in children is also 
steadily declining. This has led to the plausible hypothesis that the 
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aetiology might have be related to the standard of living and that with 
improvement in living conditions, the incidence is likely to fall further. 
 
 
ETIOPATHOGENESIS 
  
The etiopathogenesis in EHPVO has not been well elucidated. The 
theories put forward are quite heterogeneous and not well supported by 
hard evidence. Some of the aetiologies suspected are as follows. 
 
1. INFECTIONS 
Neo-natal umbilical sepsis, omphalitis, intra-abdominal sepsis either 
overt or occult have all been alleged to cause EHPVO in children.[19]  
Neonatal umbilical vein catheterisation done for intravenous infusions and 
exchange transfusions has also been implicated as a possible etiological 
factor. Abdominal sepsis has also been postulated as a causative factor in 
adults. 
 
2. CONGENITAL ANOMALIES 
Congenital anomalies of the left and right vitelline veins, from which 
the portal vein is derived are also hypothesized as a causative factor.[20] 
8 
 
 
3. PROTHROMBOTIC STATES 
Prothrombotic states have been reported to be the underlying factor in a 
small fraction of cases in children.[21,22]  In adults, an underlying 
prothrombotic state is more commonly found than in children with EHPVO. 
Underlying latent myeloproliferative disorders and the use of oral 
contraceptive pills have also been implicated in adults with EHPVO. 
 
4. ABDOMINAL TRAUMA AND SURGERY 
  Abdominal trauma and surgery has also been alleged to be a cause of 
EHPVO in a small proportion of cases. 
  
5. IDIOPATHIC 
 There is no discernible aetiology in a large proportion of cases of 
EHPVO, especially in the paediatric age group. In Indian children the 
proportion of idiopathic EHPVO is as high as 90%. [24] 
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PATHOLOGY 
  Most commonly the entire length of the portal vein is obstructed by 
the thrombus. In Indian children, it is observed that the most common site 
of obstruction is at the portal vein formation[39%], followed by the entire 
length of portal vein [34%], splenic vein [ 16%] and the entire spleno-renal 
axis [11%]. 
 
THE PORTAL CAVERNOMA: 
  The portal cavernoma is the pathognomonic feature of chronic 
EHPVO. The portal vein is grossly replaced by a sheath of variably sized 
tortuous channels in a connective tissue matrix. This is called as the portal 
cavernoma.  It is formed by the porto-portal collaterals that develop within 
the thrombosed part of the portal vein. The perfusion to the liver is hence 
not as severely compromised as would be expected otherwise. The 
development of porto-systemic collaterals occurs over time leading to the 
formation of varices at various sites in the GI tract. 
  Liver function is usually preserved and most often the histology 
reveals a normal architecture.  Alterations in the liver storage function and 
transport maximum for bromsulphalin and abnormalities in liodocaine 
excretion have been documented. Liver biopsy is usually not indicated in 
clear cut cases of EHPVO. 
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Figure1: Portal Cavernoma 
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CLINICAL FEATURES 
 
EHPVO has two clinical forms; namely Acute or recent EHPVO and 
the more common Chronic form.  
 
ACUTE EHPVO  
Most often, the acute form goes unnoticed. Sometimes, there is 
transient abdominal pain, fever or rarely ascites. There is no portal 
cavernoma formation on imaging and there is absence of varices. 
 
CHRONIC EHPVO 
The more common of the two forms, the usual clinical presentation is 
with an episode of variceal bleed. Massive splenomegaly, with or without 
features of hypersplenism is also a common mode of presentation.  
 
VARICEAL BLEEDING 
  Most children present with an episode of variceal bleeding.[25] Often 
it is a massive episode and occurs commonly in the first or second decade. 
Most often the site of bleeding is from oesophageal varices. The bleeds are 
usually well tolerated. There are no features suggestive of hepatic 
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decompensation during these episodes. Gastric varices are often seen in 
about 70% of cases. Most of these varices are gastro-oesophageal varices 
than isolated gastric varices.[26-28] The propensity for these gastric varices 
to bleed increases significantly after eradication of oesophageal varices. 
Rectal varices are also not uncommon. It is as common as 34-64%.[29] The 
incidence is probably related to the duration and location of obstruction. 
The incidence of rectal varices also increases after oesophageal varices are 
obliterated by endotherapy. 
  The risk of varices to bleed depends on their size. Larger varices have 
a greater propensity to bleed. [30] Other determinants are the vessel wall 
thickness and the supporting tissue. But these parameters are more 
difficult to assess. The precipitating factors alleged are reflux oesophagitis, 
NSAID intake and fever. [31] 
 
ABDOMINAL MASS 
Abdominal mass is the presenting feature in nearly 10% of 
children.[32] Usually the splenomegaly is massive and may enlarge to extend 
even up to the right iliac fossa. Massive splenomegaly can result in 
hypersplenism manifesting as anaemia and thrombocytopenia  
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ABDOMINAL PAIN 
 Pain most often is in the form of a dull ache secondary to the massive 
splenomegaly. Rarely splenic infarction or extension of the venous 
thrombosis may be the cause.[33] 
 
ASCITES 
Ascites occurs in a small proportion of children following variceal 
bleeding and is most often transient.[34] Very rarely children develop 
intractable ascites and these children may benefit from paracentesis or 
shunt surgery. 
 
ECTOPIC VARICES 
Ectopic varices are not uncommon and can occur in around 27-
40%.[16] Varices in the duodenum, gall bladder bed and anorectal region are 
the most common sites of ectopic varices . 
 
JAUNDICE 
Rarely jaundice may be the presenting feature of EHPVO. This occurs 
as a result of portal biliopathy. Portal biliopathy is the term given to 
abnormalities of extra hepatic and intrahepatic biliary apparatus that 
occurs as a consequence of portal hypertension.  They may result from 
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compression by the paracholedochal collaterals on the bile ducts and result 
in narrowing, strictures, angulations and irregularities of the bile ducts. 
Though features suggestive of portal biliopathy has been demonstrated in 
as high as 80-100% in adults with EHPVO, these changes are less common 
in children.[35] 
 
HYPERSPLENISM: 
Sequestration of blood cells in the spleen and premature destruction 
can manifest as pancytopenia.  Rarely a sequestration crisis can occur, 
resulting in hypovolemia and shock. 
 
GROWTH RETARDATION 
Children with EHPVO often suffer from growth retardation.[36, 37]  
Various mechanisms have been put forward to explain the reasons behind 
growth retardation. Poor absorption related to portal hypertensive 
enteropathy, impaired synthesis of growth factors like IGF 1 and IGFBP-3 
due to shunting of blood away from the liver, recurrent GI bleeds & 
infections result in growth impairment. [38]  Mesenterico-left portal vein 
shunts which by-pass the site of  obstruction and return the portal venous 
blood to the liver have been shown to result in improvement in growth 
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parameters, whereas endotherapy has not been shown to affect the growth 
trend positively. [39, 40] 
 
COGNITIVE AND PSYCHOMOTOR DEFICITS 
Overt hepatic encephalopathy is very rare in the setting of EHPVO, 
when the underlying hepatic function is normal. [41] Minimal cognitive 
deficits and psychomotor dysfunction has been reported in patients with 
EHPVO.[14,13,42] The proposed mechanism behind the neurological 
dysfunction is the shunting of the portal blood away from the liver due to 
the presence of porto-systemic collaterals; thereby compromising the 
detoxifying function of the liver.   This is an example of TYPE B hepatic 
encephalopathy – [Hepatic encephalopathy associated with porto-systemic 
shunting in the absence of intrinsic hepato-cellular disease].[43] Neuro-
psychological testing in ten patients with portal vein thrombosis revealed 
abnormalities in five patients according to a study done by Minguez B et 
al.[42]  Indian studies done in adult EHPVO patients have also shown that 
MHE is prevalent  in these patients. [44, 12] In a study by S.K. Yadav et al, 
changes in MRI and Magnetic Resonance Spectroscopy consistent with 
MHE were found in a population of EHPVO that included children, 
adolescents and adults.[45] The diagnosis of MHE remains a challenge in 
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children with EHPVO since there is a lack of standardisation in the 
psychometric tests that are conventionally employed in detecting MHE. 
 
 
Figure 2:  Classification of Hepatic Encephalopathy according to  
11th World Congress of Gastroenterology, Vienna 1998 
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MINIMAL HEPATIC ENCEPHALOPATHY 
Minimal Hepatic Encephalopathy is the mildest form in the 
wide spectrum of hepatic encephalopathy. Patients with Minimal 
Hepatic Encephalopathy have a normal mental and neurological 
status on routine clinical examination but demonstrate a variety of 
deficits neuropsychiatric and neuro-physiological deficits on 
specialized testing.  
It was previously termed as  ‘Sub-Clinical Hepatic 
Encephalopathy’, but it was recommended  by the World Congress of 
Gastroenterology that the term “Minimal Hepatic Encephalopathy” is 
a better descriptive terminology, since  the term ‘Sub-clinical’ may be 
misinterpreted to signify a lack of clinical importance. [45]  
 Although termed ‘minimal’, the impact of MHE can have a far 
greater impact on daily life activities.  In patients with cirrhosis, it 
was shown that MHE was an independent factor in decreasing the 
quality of life, even after adjusting for the Child- Pugh status. [46] MHE 
is characterized by a delayed reaction time and an abnormal 
response inhibition.[47,48]   The practical implications of these 
impediments are many. Impairment in driving skills of patients with 
MHE has been shown to exist in various studies. [49-52] 
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Patents with MHE were also impaired when it came to activities like 
social interaction, sleep, work, home-management and recreational 
activities when compared to controls. [53, 54]  Disturbances in memory are a 
common feature in MHE. [55] The working or short term memory is 
characteristically affected while the long term memory is usually intact.  
 
PATHOGENESIS OF MHE 
 The postulated pathogenesis of MHE is on the same lines as overt 
hepatic encephalopathy. Moreover, it has been shown that many patients 
with MHE eventually go on to develop overt HE, and that patients with 
MHE have nearly four times the risk of developing overt HE than those 
without.[56]. This underlines the common pathogenic mechanisms 
underlying the spectrum of Hepatic Encephalopathy.  Nitrogenous 
substances which are derived from the gut are thought to play a major role 
in the pathogenesis of MHE. Ammonia levels are significantly elevated in 
patients with HE. Ammonia has been shown to alter cerebral perfusion and 
decrease glucose utilisation in different cortical sites.  This has been shown 
to correlate well with the decline in cognitive function. [57, 58] Alterations in 
the glio-neuronal communications lead to astrocyte swelling. These 
changes seen in overt HE are also seen in MHE. Alterations in the 
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homeostasis of Manganese have also been suggested as one of the 
pathogenic mechanisms. [59, 60] 
 
DIAGNOSING MHE 
MHE by definition requires that the patient is normal on routine 
clinical examination. MHE is characterised by subtle disturbances in 
intellectual and psycho-motor function that is made out only by special 
tests. The tests can be broadly divided into Neuro-psychological tests, 
Neurophysiological tests, Computerized tests and MR imaging & 
Spectroscopy. 
 
NEURO-PSYCOLOGICAL TESTING 
These tests are simple clinical tests of cognitive function and require 
no specialised equipment. They are perhaps the most widely established 
and trusted tests to ascertain cognitive impairment. Most tests are paper 
and pencil tests that can be carried out at the bed-side. These tests require 
attention, visuo-spacial orientation and fine motor skills – faculties which 
are most affected in MHE. 
  The most common tests employed are Number Connection Tests A 
and B, the Figure connection Tests, Block Design tests and Digit Symbol 
tests. These tests are usually compared with the normative data of age and 
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education matched normal population.  Other tests which have been tried 
are the WAIS - Wechsler Adult Intelligence Scale (WAIS) for verbal and 
performance skills, Clinical Hepatic Encephalopathy Staging scale- CHESS, 
Mini Mental Status Examination etc.  
 
THE PYCHOMETRIC HEPATIC ENCEPHALOPATHY SCORE 
 This is a standardized test battery which is more specific and 
sensitive for diagnosing MHE. This consists of two trail making tests, 
namely Number connection Tests-A, Number Connection Tests-B, Serial 
Dotting Test, Digit Symbol Tests and Line tracing test.  Using the 
combination of tests has increased the accuracy in detecting MHE.  Each 
test result is said to be abnormal if it varies by greater than 2 standard 
deviations from matched normative data. MHE is diagnosed if two or more 
tests are abnormal in this battery.   Motor speed and accuracy, visuo-spatial 
orientation, visual perception, visual construction, attention, concentration, 
and memory, which are commonly challenged in patients with MHE, are 
tested in PHES. 
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NEURO-PHYSIOLOGICAL TESTS: 
These include Electro-encephalogram, Evoked potential testing, and 
Critical Flicker Frequency. The EEG changes and evoked responses are less 
specific and sensitive for diagnosing MHE. The Evoked potential testing can 
be of two types namely –Exogenous evoked potentials and Endogenous 
evoked potentials.  Among these the P300 peak obtained in an auditory 
oddball paradigm is said to have a higher sensitivity in detecting MHE. [61] 
These tests supplement psychometric tests and can be used in 
combination. The disadvantage of these tests is that they require 
specialized equipment and cannot be carried out in the out-patient 
department.  
 
CRITICAL FLICKER FREQUENCT TESTING 
 This is a type of neuro-physiological tests that is based on 
determining the threshold below which a flickering light source is 
appreciated as a continuous one.  Visual discrimination ability and general 
arousal are the faculties tested in this test. Many clinical studies have 
proven its usefulness in detecting MHE.[62-63] The test is simple and 
accurate with a high reproducibility. It also said to be less dependent on 
age, education and training 
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INHIBITORY CONTROL TEST 
This is a computerized test measuring the attention span and 
response inhibition. It has been used in testing of various psychiatric 
conditions and has also been found to be sensitive for diagnosis and follow 
up of MHE 
 
 MAGENETIC RESONANCE IMAGING AND SPECTROSCOPY 
  Changes in the form of hyper-intense signals in T1 weighted images 
of the globus pallidus have been observed in patients with cirrhosis. 
However this does not correlate with the presence or degree of Hepatic 
Encephalopathy.  
Studies using Magnetic resonance spectroscopy (MRS) have shown a 
decrease in myo-inositol/creatine and choline/creatine ratios in white 
matter with an increase in the Glx (glutamine and glutamate) concentration 
in the basal ganglia in those with MHE. [64, 65] However, its usefulness in 
diagnosis of MHE has not been firmly proven. 
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MHE IN CHILDREN WITH EHPVO 
While the prevalence and impact of MHE has been well studied in 
adults with EHPVO, the existence of MHE and its impact on the normal 
psychosocial development has not been explored in children. Since MHE 
obtunds attention span, alertness, reaction times, information processing 
and memory, its potential impact on the developing mind cannot be 
overemphasized. Whether MHE in EHPVO affects the child’s overall 
intellectual and psychological development, as well as its possible impact 
on his/her scholastic performance remains to be studied. 
     The problem of analysing this is further complicated by the lack of 
any standardized tests that have been validated for diagnosing MHE in 
paediatric population. There is no normative data available for the use of 
the psychometric tests commonly used to detect MHE. It remains to be seen 
if the same tests that are applicable in adults would also be useful in 
children with MHE. The usefulness of CFF has also not been established in 
children with EHPVO.  
     Establishing the prevalence of MHE in children with EHPVO is therefore 
a challenge that needs to be addressed earnestly. Doing so would lay the 
foundation for treatment modalities for these children which may have the 
potential to improve their overall intellectual, psychological and social 
development. 
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AIMS OF THE STUDY 
 
 
 
 To study the clinical profile of children with Extra-Hepatic Portal  
Vein Obstruction 
 
 To study the prevalence of minimal hepatic encephalopathy in 
these children, using 
1. Psychometric Tests 
2. Critical Flicker Frequency 
 
 
 
 
24 
 
MATERIALS AND METHODS 
 
STUDY DESIGN:  Cross-sectional case-control observational study 
 
STUDY CENTRE:   
Madras Medical College & Rajiv Gandhi Government General Hospital 
and Institute of Child Health, Chennai 
 
STUDY PERIOD:  July 2013- Feb 2014 
 
SAMPLE SIZE:  
 30 CASES  
 30 CONTROLS 
 
INCLUSION CRITERIA:  
 Children diagnosed to have EHPVO according to the definition 
by the Baveno V Consensus 
 Age group – 8 to 18 years 
 Doppler showing Portal Cavernoma  
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EXCLUSION CRITERIA: 
   Children with  
 Acute/Chronic  parenchymal Liver Disease  
 jaundice or portal biliopathy  
 shunt surgery in the past  
 known neurological/psychiatric disease  
 non-hepatic encephalopathies  
 children on psycho-active drugs  
 significant co-morbid illness  
 
METHODOLOGY 
Children diagnosed with EHPVO, on follow up at the 
Gastroenterology Department of Rajiv Gandhi Government General 
Hospital and Institute of Child health who satisfied the inclusion and 
exclusion criteria were taken up into the study.  
 
PILOT STUDY: 
An initial pilot study was done to determine the sample size and the 
same methodology was carried over to the actual study. 
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 In each case, a detailed history was taken to ascertain the possible 
aetiology of EHPVO. History of umbilical sepsis, neonatal umbilical vein 
catheterisation, abdominal trauma, abdominal surgeries, and abdominal 
sepsis was elicited. The age at diagnosis, number of episodes of variceal 
bleeds, the number of years since the first bleed and the number of 
endotherapies performed were all recorded. 
 
A thorough clinical examination including anthropometric data, 
general examination and per abdomen findings were noted. The 
anthropometric data was plotted against IAP Growth charts separate for 
Indian Girls and boys. The percentile under which their height for age falls 
was noted. If a child’s weight was found to be less than the third percentile 
of the population for the particular age group, it was taken to signify 
growth retardation. 
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Figure 3: IAP Growth chart for Indian Boys -2-18 yrs 
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Complete hemogram, Liver function tests, serological markers of 
chronic viral hepatitis –HBsAg and Anti HCV were performed.                 
Portal venous Doppler was done to confirm the diagnosis. Upper GI 
endoscopy findings, with respect to the presence and grade of oesophageal 
and gastro-oesophageal varices were collected from the child’s medical 
records.  
 
CONTROLS: 
 Controls were selected from a school in Chennai, so as to match the 
study group with respect to age and the class of study at school. The 
psychometric and CFF testing was done in the study group and the 
normative data was compiled. 
 
PSYCHOMETRIC TESTS: 
The following psychometric tests were performed in all the children.  
                      1) Number Connection Tests A & B & T  
                      2)  Digit Symbol Test  
                      3)  Serial dot test  
                      4)  Line tracing test and  
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NUMBER CONNECTION TESTS A, B & T 
These simple trail making, ‘paper-pencil’ tests were carried out and 
the time taken to complete each test was recorded. If the child were to 
make an error in these tests, it was quickly pointed out and corrected and 
the time recorded was the time included for correction. The Number 
connection Test –T was devised to nullify the disadvantage that children 
who had the medium of instruction as Tamil, had while performing NCT-B 
test. Each test was preceded by a sample test to ensure that the child 
understood what was required of her/him. 
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NUMBER CONNECTION TEST - A 
 
 
Figure 4: NCT- A 
The child is asked to join one numeral to the next in ascending order and 
the time taken to complete the entire sequence is noted in seconds. 
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NUMBER CONNECTION TEST - B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: NCT - B 
 
The child is asked to join the numerals to their corresponding alphabet and 
the time taken to complete the sequence is noted in seconds. 
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NUMBER CONNECTION TEST – T 
Figure 6: NCT - T 
The child is asked to join each numeral with the corresponding Tamil 
alphabet in sequence. The time taken to complete the test is noted in 
seconds. 
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DIGIT SYMBOL TEST 
This test requires the child to substitute a symbol below each 
numeral according to a key. The time required for the child to complete 
three rows of the test was noted. This too had a practice run before the 
actual test. 
 
Figure 7: Digit Symbol Test 
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SERIAL DOTTING TEST 
This test requires the child to keep dots serially approximately at the 
centre of the circles. The time required to complete the chart was the score 
of the test. 
 
Figure 8: Serial Dotting Test 
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LINE TRACING TEST 
  
The child was required to trace a line using a pencil, within the track 
in the picture without. The time required to complete the trail was the 
score. Penalty seconds were added for touching the track borders.  
 
Figure 9: Line Tracing Test 
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CRITICAL FLICKER FREQUENCY ESTIMATION: 
 
This was carried out using MEDIGRAPH CFF apparatus. The flicker 
frequency of the instrument ranged from 5 to 70flickers per second. The 
light source had the option of green and red light. Only red light was used 
in all the recordings.  All recordings were made in a semi-darkened room 
by slowly increasing the frequencies until the flickering was perceived as a 
continuous light. This frequency was noted. Four consecutive readings 
were recorded and the mean was calculated as the critical flicker 
frequency. 
 
Figure 10: MEDIGRAPH –CFF APPARATUS 
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STATISTICAL ANALYSIS 
 
The sample size of 60 [30 cases and 30 controls] was calculated 
based on the pilot study values done for 7 cases and 7 controls.  G Power 
3.0.10 software was used. The α value was set at 0.05 and the sample size 
was calculated for a power of 0.95. Data processing was done using the 
software packages SPSS. Mean and standard deviation was calculated.  
Levene's Test for Equality of Variances and  t-test for Equality of Means was 
used for comparison between cases and controls. Pearson Chi square test 
and Fischer’s exact test was used for correlation between tests. 
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RESULTS 
Table 1: BASELINE CHARACTERISICS OF THE CASES 
CHARACTERISTICS MEAN +/- SD [RANGE] 
AGE  10.67± 1.32 yrs 
SEX [M:F]  12:18  
AVERAGE AGE AT DIAGNOSIS / RANGE 6.47 yrs /[1-12 YEARS] 
AVERAGE YEARS SINCE DIAGNOSIS  4.2 yrs 
BLEEDERS vs NON-BLEEDERS 29:1  
NO. OF EPISODES OF BLEED [RANGE] 1.83 [0-10 ] 
AVERAGE NUMBER OF ENDOTHERAPIES 10.93 [0-23] 
HAEMOGLOBIN 10.51 [8.9-12] gm% 
BILIRUBIN 0.86 [0.6-1.2] mg/dl 
AST 27.83[ 22-34] IU/L 
ALT 27.57[18-36] IU/L 
ALBUMIN 3.63[3.4-3.9] gm/dl 
 
Table 2: BASELINE CHARACTERISTICS OF CONTROLS 
AGE  10.67± 1.32  
SEX [M:F]  10:20  
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AGE: 
The average age of the cases was 10.67 years. The range was from 8 
to 13 years. The average age of the controls was identical to the control 
group, since they were matched before enrolling them for the tests 
 
 
SEX DISTRIBUTION: 
There were totally 12boys [40%] and 18 girls [60%] in the study.  
 
 
Chart 1: Sex distribution of Cases 
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MODE OF INITIAL PRESENTATION 
The most common mode of initial presentation was variceal bleed in 
80%, followed by abdominal mass in 14%. Fever and anaemia were 
presenting features in 3% each. 
 
 
 
Chart 2: Mode of Initial Presentation 
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AETIOLOGY 
 In most of the children, no antecedent etiological history could be 
elicited. A history suggestive of umbilical sepsis was present in 6 children. 
 
 
 
Chart 3: Aetiology of EHPVO 
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VARICEAL BLEEDING 
Out of the thirty children, only one child was not a bleeder [3% vs 
97%].  But he too had evidence of varies at endoscopy. The number of 
episodes of bleeding was quite variable with a range of 1 to 10 with a mean 
of nearly 2 episodes. Most of the patients [87%] had had a history of 
endotherapy. The average number of endotherapies performed one each 
child was 11 and it ranged from 0 to 23.  
 
 
Chart 4: Bleeders vs Non-bleeders 
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GROWTH RETARDATION: 
The distribution of the study population according to the growth 
percentile is as given below. 
 
Table 3: Height for age 
 
HT FOR AGE 
 
CASES 
 
PERCENTAGE 
<3rd percentile 5 17% 
3-25th 14 46% 
25th-50th 8 27% 
50-75th 1 3% 
70-90th 2 7% 
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Chart 5: Height for age, distribution 
 
 
Most of the children were between the 3rd and 25th percentile for ht 
appropriateness for age. 5 children [17%] had an ht less than the 3rd 
percentile for age signifying growth retardation.  
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UPPER GI ENDOSCOPY: 
All thirty cases had varices at upper GI endoscopy. 
 
Table 4: Type of Varix 
VARIX NUMBER Of CHILDREN 
SMALL ESOPHAGEAL VARIX 6 
LARGE ESOPHAGEAL VARICES 16 
GOV 18 
 
 
Chart 6: Type of Varix at Endoscopy 
 
 
15%
40%
45% SMALL ESOPHAGEAL 
VARIX 
LARGE ESOPHAGEAL 
VARICES 
GOV 
46 
 
PSYCHOMETRIC TEST SCORES 
The mean normative scores derived from the control group for NCTA 
was 46.17±19.44, for NCT-B -77.53±26.66, NCT-T70.83±30.38, DST - 
140.4±20.09, SDT - 46.77±9.88 and LTT - 54.97±11.66. The mean score for 
the study group was NCT-A- 73.9±32.87, NCT-B-148.87±71.7, NCT-T-
108.37±43.62, DST - 236.00±89.63, SDT - 53.53±14.06 and LTT - 72.53 ± 
19.06  
Table 5: Psychometric Test Scores – Comparison of Means 
TEST CONTROLS [Sec] CASES [Sec] SIGNIFICANCE [p value] 
NCT-A 46.17±19.44 73.9±32.87 <0.001 
NCT-B 75.3±26.66 148.87±71.7 <0.001 
NCT-T 70.83±30.38 108.37±43.62 <0.001 
DST 140.4±20.09 236.00±89.63 <0.001 
SDT 46.77±9.88 53.53±14.06 0.036 
LTT 54.97±11.66 72.53±19.06 <0.001 
 
 
The mean scores for the cases were higher than those of the controls.       
The difference between the mean test scores between the control group 
and study group was statistically significant for all the tests. 
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Chart 7: Psychometric Test Scores – Comparison of Means 
 
PSYCHOMETRIC TEST RESULTS 
The prevalence of abnormal psychometric tests in the study group 
according to each test is as follows… NCT-A - 9[30%], NCT-B - 15 [50%],  
NCT-T  - 9[30%], DST - 18[60%] , SDT - 3[10%] , LTT - 9[30%] .  Minimal 
hepatic encephalopathy was said to be present if at least two psychometric 
tests were abnormal [>2S.D from mean]. Accordingly, MHE was present in 
15 of the children. Except for serial dotting test, all tests correlated 
individually with the presence of MHE.  
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Table 6: Yield of each individual test 
TEST Abnormality in 
cases 
Corrrelation with 
MHE  [p value] 
NCT-A 9[30%] 0.001 
NCT-B 15 [50%] 0.001 
NCT-T 9[30%] 0.001 
DST 18[60%] 0.001 
SDT 3[10%] 0.068 
LTT 9[30%] 0.005 
 
 
Chart 8: Yield of each Psychometric Test 
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The sensitivity and specificity of each test for predicting MHE is as follows. 
 
 
Table 7: Sensitivity and Specificity of each psychometric test for MHE 
TEST SENSITIVITY SPECIFICITY 
NCT-A 60 % 100 % 
NCT-B 86.67 % 86.67 % 
NCT-T 60 % 100 % 
DST 100 % 80 % 
SDT 20 % 100 % 
LTT 53 % 93 % 
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CRITICAL FLICKER FREQUENCY 
The mean CFF value of the control group was 48.05 with a S.D of 1.12 
flickers. The cut off for detecting MHE was 45.8 [< 2 S.D of mean]. The mean 
CFF of the cases was 46.016. 
Table 8: CFF controls vs Cases 
 CONTROLS CASES p value 
CFF  48.05±1.12  46.016  <0.001 
 
The sensitivity and specificity of CFF in predicting MHE with respect to 
PHES was 80% and 86% respectively. 
 
 
Chart 9: Sensitivity and Specificity of each psychometric test and CFF 
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DISCUSSSION 
 
In this study the clinical profile of children with EHPVO and the 
prevalence of Minimal Hepatic Encephalopathy were studied using 
psychometric tests and critical flicker frequency.  
All the children in our study were chronic forms of EHPVO, on follow 
up at the gastroenterology OPD.  All of them had evidence of portal 
cavernoma on portal doppler imaging.  
The most common mode of initial presentation of the cases was with 
an episode of variceal bleeding.  Eighty percent of children had presented 
with an episode of variceal bleed. Studies by Arora et al [27] and Poddar [25] 
have shown that variceal bleeding is the presenting feature in 85%-90% of 
cases, similar to our study. In our study abdominal mass was the presenting 
feature in 14% of cases.  One child had been admitted for fever and during 
evaluation, was found to have underlying chronic EHPVO and another was 
found to have EHPVO while being evaluated for anaemia and splenomegaly. 
History suggestive of neonatal umbilical sepsis was forthcoming in 6 
cases.  Most of these children had been delivered at home. In nearly 80% of 
the cases, no antecedent cause could be elicited in their history. Studies by 
Poddar et al have shown that nearly 90% of cases of EHPVO are 
idiopathic.[24] The reason probably lies in the fact that most acute forms of 
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EHPVO have minimal clinical features and thus are often overlooked. As the 
disease becomes chronic, it presents more dramatically, by which time the 
initial acute event is not correlated with.  
The anthropometric data of our study suggests that nearly 17% of 
them were short statured; that is their height for age was less than the 3rd 
percentile for Indian children. According to the study by Mehrotra R N, 
Batia V et al, the prevalence of growth retardation in children with EHPVO 
was as high as 50%.[36] But the definition of growth retardation taken in 
this study was a height less than the 5th percentile, instead of the 3rd 
percentile.  Therefore, the prevalence of growth retardation was 
overestimated in this study. 
Twenty nine out of the thirty children with EHPVO had a history of 
variceal bleed. At endoscopy 85% of them had large varices. Though 
literature states that nearly 70% have gastric varices, [26, 27] in our study 
only 45% of the children had gastric varices- all in conjuction with 
oesophageal varices. None of them had isolated gastric varices.  
All the children were able to complete the psychometric tests in our 
study. The number connection tests B and T were the most difficult and 
most prone for corrections. The NCT-T was introduced in our study to 
eliminate the disadvantage a child might have due to differences in their 
language of instruction at school. There were differences in the mean 
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scores between NCT-B and NCT-T in both groups. The NCT-T test had a 
lower mean score compared to NCT-B in both the groups; though 
essentially these tests are identical except for the language used. This 
suggests that regional language has a great role to play when it came to 
arriving at normative data for psychometric tests in a particular 
population. Ours being a diverse population with respect to language, 
normative data of NCT-B in different regional languages tests would 
probably be required in studies in the Indian population. Figure connection 
tests can overcome this problem, but are more time consuming than the 
NCT tests. 
In our study the mean score of all the tests were higher in the study 
group compared to the controls. This difference was statistically significant 
for all the tests [p value <0.05]. When compared between the cases and 
control groups the difference in the average score were higher for the DST 
and the NCT-B tests. These tests also had the highest sensitivity in 
detecting Minimal Hepatic Encephalopathy. They were also the least 
specific. It may well serve that these two tests can be used as screening 
tests and if positive, the child can be subjected to the entire battery of tests. 
The prevalence of MHE in our study was 50% according to 
psychometric analysis; i.e. 15 children had two or more test scores which 
were abnormal. The test score was said to be abnormal if it was greater 
54 
 
than 2 S.D from the control group. Studies on in adults with EHPVO have 
shown that the prevalence of MHE in them to be around 40-45%.[67-68]      
The inclusion of an additional test in the form of NCT-T probably explains 
the slightly higher incidence in our study. The proposed pathogenic 
mechanism behind the pathogenesis of MHE in EHPVO is the chronic porto-
systemic shunting of blood bypassing the liver.  In our study we found no 
statistically significant association between the duration of the disease and 
the presence of minimal hepatic encephalopathy.  
Critical Flicker frequency estimation was done in the control and 
study population. The test was carried out after explaining the test in detail 
and it was made sure before the test that they understood what was 
expected of them in this test. . The instrument used was the Digital Critical 
Flicker fusion apparatus from MEDI-Systems India. Consequently the same 
cut-off of 38 Hz used in other studies which have used the HEPATOnorm 
CFF analyzer- Germany, could not be adopted in our study. The cut-off in 
our study was derived from the CFF thresholds obtained using our 
instrument in the control group. Fourteen children with EHPVO had an 
abnormal CFF reading compared to the controls. CFF had a good 
consistency in predicting MHE detected based upon psychometric tests. 
The sensitivity and specificity of CFF in detecting MHE was 80% and 86% 
respectively in our study. In the study by Manuel Romero –Gomez et al, 
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similar rates of sensitivity [76.2%] but a slightly lower rate of specificity 
[61.4%] was reported for CFF in detecting MHE.[63] But in this study it was 
entirely  an adult population which was assessed. 
The impact of MHE on the child’s overall intellectual development 
needs to be analysed further. Whether the presence of MHE has a bearing 
on the child’s academic performance is also an area of research that has to 
be explored. If it were the case, then it would deem fit that these children 
received additional care, assistance and support with their curricular work 
and endeavours. Treatment modalities have been tried and have been 
shown to be beneficial in MHE occurring in adult patients with EHPVO. [68] 
The scope for similar treatment modalities in EHPVO children with MHE 
merits future studies.  
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CONCLUSIONS 
 
1. Minimal Hepatic Encephalopathy does exist in children with Extra 
Hepatic Portal Vein Obstruction. 
2. Prevalence is as high as 50% when psychometric tests are used  
and 46% when Critical Flicker Fusion is used. 
3. Digit Symbol Test, Number Connection Test - B are highly 
sensitive among psychometric tests in detecting Minimal Hepatic 
Encephalopathy and can be used as initial screening tests.  
4. Critical Flicker Fusion has a good sensitivity and specificity in 
detecting Minimal Hepatic Encephalopathy and correlated well 
with psychometric tests. 
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CONTROLS
S. No Name AGE SEX NCT-A NCT-B NCT-T DST SDT LTT CFF
1 DHANAM 8 F 29 86 60 159 60 60 49
2 KARTHIK 8 M 88 105 132 193 58 89 47
3 SHWETHA 10 F 38 85 84 117 46 41 46
4 JEBASTIN 10 M 78 150 93 170 50 77 48.5
5 TAMILSELVI 11 F 32 93 71 148 35 45 48.5
6 NIBEN 11 M 52 70 78 167 63 60 48.5
7 SARASWATHI 12 F 28 56 99 143 40 49 47
8 BHAVANI 11 F 45 52 77 122 50 46 46
9 LOHITHA 11 F 37 33 23 138 61 63 47
10 VINODHINI 11 F 52 113 43 100 55 60 48.5
11 GOPIKA 11 F 64 85 125 165 57 57 48.5
12 KIRAN 11 M 71 99 63 135 63 61 48.5
13 ADHISHTALAKSMI 10 F 47 77 131 157 47 50 47
14 JENISHA 12 F 24 38 17 106 29 48 48.5
15 SWARNA 13 F 29 49 51 131 37 41 48.5
16 KAVYA 13 F 28 55 37 130 31 37 48.5
17 MOHAMMED 9 M 80 95 95 140 51 69 48.5
18 JEBARAJ 9 M 79 113 95 149 45 68 49
19 DELEIYA 10 F 42 91 73 127 56 53 49
20 BENNY 9 M 25 79 73 143 43 67 49
21 YOGESHWARI 11 F 54 76 80 160 41 41 49
22 CHARUMATHI 11 F 28 48 56 142 42 50 49
23 JANANI 12 F 39 78 32 119 34 53 49
24 SUDHARNA 12 F 23 53 27 119 37 49 49
25 PARVEEN 12 F 22 37 43 134 38 48 47
26 YOGESH 10 M 57 97 93 156 55 48 46
27 BHANU 10 F 58 92 76 137 48 49 49.5
28 BINDHU 9 F 61 95 87 140 46 68 49.5
29 SARAVANAN 11 M 48 74 68 141 51 53 46
30 MANI 12 M 27 52 43 124 34 49 46.5
CASES
S. No Name AGE SEX DiagnosisAge at DiagnosisEpi odes of bleedMODE OF PRESENTATIONYears since diagnosisYears since first BleedHB BILIRUBIN AST
1 MYTHILI 8 F Unknown 8 0 ABDOMINAL MASS 0 0 10.4 0.8 23
2 ANBUMANI 8 M Omphalitis 5 2 VARICEAL BLEED 3 3 9.8 0.9 28
3 DIANA 10 F Unknown 5 1 ABDOMINAL MASS 5 1 11.6 0.8 23
4 HARISH KUMAR 10 M Unknown 5 1 FEVER 5 1 10.8 0.8 29
5 YOGESHWARI 11 F Unknown 7 1 VARICEAL BLEED 4 7 12 0.6 28
6 THOMAS 11 M Unknown 11 1 VARICEAL BLEED 0 0.5 8.9 0.8 34
7 MENAKA 12 F Omphalitis 10 2 VARICEAL BLEED 2 2 10.7 0.8 33
8 ABITHA 12 F Unknown 8 1 ANAEMIA 4 0.5 9.2 0.7 29
9 VANAJA 11 f Unknown 8 2 VARICEAL BLEED 3 3 11 0.8 24
10 SHARMILA BANU 12 F Unknown 9 1 VARICEAL BLEED 3 3 12 0.9 33
11 SAMUEL 9 M Unknown 6 2 VARICEAL BLEED 3 3 12 0.8 23
12 BALAJI 10 M Omphalitis 5 1 VARICEAL BLEED 5 5 10 1.1 23
13 GOVARDHAN 12 M Unknown 12 1 VARICEAL BLEED 0 0.5 11 1 22
14 PRIYANKA 10 F Unknown 10 1 VARICEAL BLEED 0 0.25 9.8 1 22
15 DIKSHITHA 11 F Omphalitis 4 6 VARICEAL BLEED 7 7 11 1 32
16 NANDINI 11 F Unknown 3.5 1 VARICEAL BLEED 7.5 3 8.9 0.9 32
17 NIRANJANA 9 F Unknown 1.5 1 VARICEAL BLEED 7.7 7.5 9.8 0.7 26
18 DILLI RANI 11 F Unknown 2 2 VARICEAL BLEED 9 2 10 0.9 30
19 KANNAN 12 M Unknown 6 3 ABDOMINAL MASS 6 6 11 0.7 30
20 NIRMAL KUMAR 11 M Omphalitis 7 2 VARICEAL BLEED 4 4 10.2 1.2 23
21 DHINA 10 M Unknown 1 10 VARICEAL BLEED 9 9 8.9 0.8 32
22 SOWMYA 11 F Unknown 7 1 VARICEAL BLEED 4 6 11 0.7 30
23 PRIYANKA 13 F Unknown 8 1 VARICEAL BLEED 5 0.5 10.4 0.8 28
24 YUVARAJ 9 M Unknown 6 1 VARICEAL BLEED 3 1.5 10.8 1.1 26
25 HARIHARAN 10 M Unknown 5 1 VARICEAL BLEED 5 1 10.6 1 23
26 SARAVANAN 9 M Unknown 6 2 VARICEAL BLEED 3 3 10.2 0.7 30
27 MONIKA 12 F Omphalitis 10 2 VARICEAL BLEED 2 2 11 0.9 28
28 SEETHA 11 F Unknown 2 2 ABDOMINAL MASS 9 2 9.8 0.9 30
29 PAVITHRA 13 F Unknown 8 1 ABDOMINAL MASS 5 0.5 11 1 28
30 VANAJA 11 F Unknown 8 2 VARICEAL BLEED 3 3 11.4 0.8 33
ALT ALBUMIN OGD Endotherapy Ht Wt BMI NCT-A NCT-B NCT-T DST SDT LTT CFF Value
30 3.6 LV 0 120 20 13.89 73 159 161 319 61 73 45.5
21 3.6 LV+GV 10 128 23 14.02 70 119 151 208 58 61 45
33 3.7 LV 9 128 19.5 11.89 87 169 92 216 55 75 45.5
23 3.5 LV 15 125 20 12.82 114 313 158 445 95 99 44.5
28 3.4 LV 17 138 28 14.74 78 278 121 274 52 50 46.5
31 3.6 SV 4 141 29.5 14.9 36 97 60 153 49 79 47
23 3.8 LV 9 129 20.5 12.35 35 121 71 135 49 70 46.5
29 3.6 SV 9 132 24 13.79 50 70 89 202 53 71` 46
31 3.8 LV 0 136 26.3 14.29 46 86 60 158 49 45 47
33 3.5 SV 11 140 35 17.86 28 72 53 143 48 53 47
30 3.8 LV+GV 5 123 20.5 13.58 79 200 155 326 64 118 45.5
28 3.8 LV 14 124 18.5 12.01 136 132 109 295 70 78 45
31 3.5 SV 4 140 26 13.27 97 210 200 242 46 92 44.5
36 3.8 LV 0 126 24 15.19 140 199 200 420 49 86 45
21 3.6 LV+GV 20 131 24 14.04 113 107 109 304 40 80 48
32 3.6 LV 17 135 28 15.38 56 115 37 154 43 63 47.5
31 3.4 LV 16 127 22 13.67 63 133 89 188 48 75 47
31 3.5 LV+GV 19 140 27 13.78 48 164 112 166 38 61 45
30 3.9 LV 14 153 37.5 16.03 71 106 107 235 44 50 48
23 3.5 LV 17 133 26.5 14.97 85 108 82 222 48 66 47.5
18 3.5 LV 7 132 23 13.21 89 152 89 239 44 88 44
26 3.4 LV 23 136 26.3 14.21 52 46 67 180 39 54 46
30 3.4 SV 9 133 25 14.12 47 78 67 171 49 72 48
32 3.7 LV 22 123 23 15.23 144 257 177 283 61 51 44.5
26 3.8 LV 15 125 21 13.46 118 319 160 438 98 97 44
23 3.4 LV+GV 5 123 20.5 13.56 79 200 155 326 64 118 45
19 3.8 LV 9 129 20.5 12.41 38 124 76 138 51 71 48
28 3.8 SV 19 140 27 13.78 49 166 114 169 39 63 44.5
28 3.7 LV+GV 9 133 25 14.12 49 79 69 172 51 71 47
22 3.9 LV 0 136 26.3 14.21 47 87 61 159 51 46 46
ACRONYMS & ABBREVIATIONS 
EHPVO – Extra Hepatic Portal Vein Obstruction 
HE – Hepatic Encephalopathy 
MHE – Minimal Hepatic Encephalopathy 
PHT – Portal Hypertension 
NSAID – Non-Steroidal Anti-Inflammatory Drugs 
MRI – Magnetic Resonance Imaging 
CHESS – Clinical Hepatic Encephalopathy Staging Scale 
WAIS – Wechsler Adult Intelligence Scale 
NCT-A – Number Connection Test-A  
NCT-B – Number connection Test-B     
NCT-C – Number Connection Test-Tamil  
 SDT – Serial Dotting Test 
DST – Digit Symbol Test 
LTT – Line Tracing Test   
GI – Gastro-Intestinal  
UGI – Upper Gastrointestinal  
IGF – Insulin-like Growth Factor 
IGFBP – Insulin-like Growth Factor Binding Protein 
PROFORMA 
Minimal Hepatic Encephalopathy in Children with EHPVO 
                                                                                                                  Date: 
Name:                                                                                                Age/Sex: 
Standard/School:                                                                             Medium:                               
 
Address:                                                                                            SE status: 
 
Phone Number:                                                          Immunisation Status: 
 
Diagnosis: 
 
Aetiology of EHPVO:   Omphalitis / Umblical  Cannulation / abd. Sx / Trauma/ 
                                                     Recurrent Diarrhoea / Unknown 
 
Age at Diagnosis: 
 
History of UGI Bleed:  
                        No. of episodes: 
                                 First Bleed: 
                                 Last Bleed: 
 
History of Endo-therapy: 
 
Drug History: 
 
 
O/E: 
 
 
Ht:                                  Wt:                                                            BMI: 
 
 
P/A: 
  
LFT: 
 
 
 
Viral Markers: 
 
USG: 
 
 
 
Doppler/CT Angio/MR angio: 
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OGD: 
 
 
 
Critical Flicker Frequency: 
 
Number Connecion Test  A -  Sample 
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Score: 
Number Connection Test B - Sample 
                       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number Connection Test –B 
 
 
 Score: 
Number connection Test B- Tamil Sample 
 
 
 
 
Number Connection Test B – Tamil 
 
Score: 
Digit Symbol Test 
 
 
 
 
 
Score: 
Serial Dotting Test 
  
Score: 
Line Tracing Test 
 
                                 
 
 
 
 
Time Score: 
Error Score: 
Total Score: 
Information Sheet and Consent 
 
                 
We are conducting a study on “Hepatic Encephalopathy in Children with Extra-
Hepatic Vein Obstruction”, at The Department of Medical Gastroenterology –       
Rajiv Gandhi Government General Hospital, Chennai and Institute of Child Health, 
Chennai. The purpose of this research is to study the prevalence of Minimal Hepatic 
Encephalopathy in school children with Extra-Hepatic Portal Vein Obstruction and 
when present, to assess its relation to the extent of Porto-systemic collaterals. 
            The privacy of your child in the research will be maintained throughout the 
study. In the event of any publication or presentation resulting from the research, no 
personally identifiable information will be shared. 
           Taking part in this study is voluntary. You are free to decide on whether your 
child participates in this study and are fee to withdraw him/her from this study at 
any time. Your decision will not result in any loss of benefits to which your child may 
otherwise be entitled. 
            The results of the study may be intimated to you at the end of the study 
period or during the study if anything is found abnormal. This may aid in your child’s 
management and treatment. 
 
 
 
 
Signature of the Investigator                                    Signature of the Parent/Guardian 
 
 
 
 
 
 
 
  
 
 
 
 
  
